Insider trade

Insider sold ~$17.2M of ROIV shares in the open market

Traded Nov 19, 2025 · Filed Nov 22, 2025

Why it stands out

Roivant Sciences's Reporting person sold $17.2M of Roivant Sciences shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

InsiderIndirect holding$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$17,212,500

Shares × reported transaction price

Timing vs results

9 days after results of Nov 10, 2025, 79 days before results of Feb 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−0.4%	+1.7%	−2.1%
30 days	+10.8%	+3.2%	+7.6%
90 days	+36.8%	+2.0%	+34.7%
180 days	+46.1%	+12.2%	+33.9%

Past results only. Not a forecast.

Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 28,081,635 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.
QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.